Transpek Industry Ltd-$ — earnings calls
1 quarter summarised from transcripts filed with the exchange, every statement cited. Newest first.
Q1 FY27 earnings call
Transpek reported Q1 FY27 revenue of Rs 155.1 crore, down 6.5% year-on-year, with EBITDA of Rs 24.1 crore, lower by 32.4%, and an EBITDA margin of 15.6%. Management said the DuPont aramid contract has been fully assigned to Arclin with unchanged demand and terms, and renewal discussions are expected between the last quarter of this calendar year and the first quarter of next. Management also described ongoing product development across polymers, additives, sulfonation chemistry and chloro-fluoro compounds, along with a planned new manufacturing site in Odisha and a multi-purpose pilot plant at the existing Ekalbara site.